API Synthesis and Manufacturing, Large Molecule

CordenPharma Expands Lipid Supply for Moderna

June 04, 2020

CordenPharma announces expansion of lipid excipients supply for coronavirus vaccine scale up.

Plasma-Based Antibody Therapies Battle Against COVID-19

June 01, 2020

BioPharm International

Therapies for early and late treatment and passive immunization of COVID-19 are needed and can be developed using antibodies from recovered patients.

Can Vaccine Development Be Safely Accelerated?

April 01, 2020

BioPharm International

Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.

Bovine Heparin Meets Acceptable Impurity Levels

February 17, 2020

An evaluation by USP indicates bovine heparin is a potential alternative to porcine heparin.

Polyplus-transfection Expands GMP Portfolio for Gene and Cell Therapy Manufacturing

January 06, 2020

The new GMP conditioning product offering is designed to support clinical phase and commercialization stages of cell and gene therapy production.

Seeking Solutions for Large-Scale GMP Viral Vector Manufacturing

September 01, 2019

BioPharm International

Innovation in manufacturing technologies must occur to ensure the availability of gene and cell therapies.

Advances in Engineering of Protein-Based APIs

February 01, 2019

BioPharm International

New platform technologies, advanced modeling tools, and addressing patient needs are important developments.

ADC Bio Secures Additional Equity Round Investment

November 26, 2018

ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.

FDA Grants Support Research in Modernizing Pharmaceutical Manufacturing

August 16, 2018

FDA grants support US research in continuous manufacturing monitoring and control techniques for bio/pharmaceutical manufacturing at Rutgers, MIT, and Georgia Tech.

Avalon GloboCare Partners with Weill Cornell Medical College for CAR-T Production Technologies

August 08, 2018

Avalon and Weill will co-develop bio-production and standardization procedures for CAR-T therapy.